Effects of daily and overnight wear of hyper-oxygen transmissible rigid and silicone hydrogel lenses on bacterial binding to the corneal epithelium: 13-month clinical trials.

Harrison D Cavanagh, Patrick Ladage, Kazuaki Yamamoto, Susanna L. Li, Walter M Petroll, James V. Jester

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

PURPOSE: For 14 years, the U. S. Food and Drug Administration (FDA) and eye care practitioners have strongly discouraged patients from sleeping in contact lenses. In the past 9 months however, the FDA has approved three new hyper-oxygen transmissible lenses for up to 30-night extended wear. Is this a great advance or another clinical triumph of hope over experience? What should the public know? What should patients do? METHODS: Our research group has studied all three new lenses in prospective, randomized, masked, parallel clinical trials in a single center. As an outcome measure, we looked at whether lens wear caused more bacterial binding to surface corneal cells. RESULTS: Compared with conventional lens use, the new lenses caused no or only small increases in bacterial binding in either daily or extended wear. Furthermore, the increases seen stratified with known infection risks by both lens type (hard or soft) and wearing schedule. Indeed, early epidemiologic reports indicate that this new generation of lenses may reduce lens-related microbial infection risks by 10- to 40-fold. CONCLUSION: This represents a true clinical paradigm shift of the first magnitude in safety of contact lens wear. Taken together, this data suggest that patients will soon replace their current, conventional lenses with this new generation of materials for any schedule of wear.

Original languageEnglish (US)
JournalEye & contact lens
Volume29
Issue number1 Suppl
StatePublished - Jan 2003

Fingerprint

Corneal Epithelium
Hydrogel
Silicones
Lenses
Clinical Trials
Oxygen
Contact Lenses
United States Food and Drug Administration
Appointments and Schedules
Eye Protective Devices
Infection
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Effects of daily and overnight wear of hyper-oxygen transmissible rigid and silicone hydrogel lenses on bacterial binding to the corneal epithelium : 13-month clinical trials. / Cavanagh, Harrison D; Ladage, Patrick; Yamamoto, Kazuaki; Li, Susanna L.; Petroll, Walter M; Jester, James V.

In: Eye & contact lens, Vol. 29, No. 1 Suppl, 01.2003.

Research output: Contribution to journalArticle

@article{e0c2ae6eab2243a6bfe3290005d5e6a2,
title = "Effects of daily and overnight wear of hyper-oxygen transmissible rigid and silicone hydrogel lenses on bacterial binding to the corneal epithelium: 13-month clinical trials.",
abstract = "PURPOSE: For 14 years, the U. S. Food and Drug Administration (FDA) and eye care practitioners have strongly discouraged patients from sleeping in contact lenses. In the past 9 months however, the FDA has approved three new hyper-oxygen transmissible lenses for up to 30-night extended wear. Is this a great advance or another clinical triumph of hope over experience? What should the public know? What should patients do? METHODS: Our research group has studied all three new lenses in prospective, randomized, masked, parallel clinical trials in a single center. As an outcome measure, we looked at whether lens wear caused more bacterial binding to surface corneal cells. RESULTS: Compared with conventional lens use, the new lenses caused no or only small increases in bacterial binding in either daily or extended wear. Furthermore, the increases seen stratified with known infection risks by both lens type (hard or soft) and wearing schedule. Indeed, early epidemiologic reports indicate that this new generation of lenses may reduce lens-related microbial infection risks by 10- to 40-fold. CONCLUSION: This represents a true clinical paradigm shift of the first magnitude in safety of contact lens wear. Taken together, this data suggest that patients will soon replace their current, conventional lenses with this new generation of materials for any schedule of wear.",
author = "Cavanagh, {Harrison D} and Patrick Ladage and Kazuaki Yamamoto and Li, {Susanna L.} and Petroll, {Walter M} and Jester, {James V.}",
year = "2003",
month = "1",
language = "English (US)",
volume = "29",
journal = "Eye and Contact Lense",
issn = "1542-2321",
publisher = "Lippincott Williams and Wilkins",
number = "1 Suppl",

}

TY - JOUR

T1 - Effects of daily and overnight wear of hyper-oxygen transmissible rigid and silicone hydrogel lenses on bacterial binding to the corneal epithelium

T2 - 13-month clinical trials.

AU - Cavanagh, Harrison D

AU - Ladage, Patrick

AU - Yamamoto, Kazuaki

AU - Li, Susanna L.

AU - Petroll, Walter M

AU - Jester, James V.

PY - 2003/1

Y1 - 2003/1

N2 - PURPOSE: For 14 years, the U. S. Food and Drug Administration (FDA) and eye care practitioners have strongly discouraged patients from sleeping in contact lenses. In the past 9 months however, the FDA has approved three new hyper-oxygen transmissible lenses for up to 30-night extended wear. Is this a great advance or another clinical triumph of hope over experience? What should the public know? What should patients do? METHODS: Our research group has studied all three new lenses in prospective, randomized, masked, parallel clinical trials in a single center. As an outcome measure, we looked at whether lens wear caused more bacterial binding to surface corneal cells. RESULTS: Compared with conventional lens use, the new lenses caused no or only small increases in bacterial binding in either daily or extended wear. Furthermore, the increases seen stratified with known infection risks by both lens type (hard or soft) and wearing schedule. Indeed, early epidemiologic reports indicate that this new generation of lenses may reduce lens-related microbial infection risks by 10- to 40-fold. CONCLUSION: This represents a true clinical paradigm shift of the first magnitude in safety of contact lens wear. Taken together, this data suggest that patients will soon replace their current, conventional lenses with this new generation of materials for any schedule of wear.

AB - PURPOSE: For 14 years, the U. S. Food and Drug Administration (FDA) and eye care practitioners have strongly discouraged patients from sleeping in contact lenses. In the past 9 months however, the FDA has approved three new hyper-oxygen transmissible lenses for up to 30-night extended wear. Is this a great advance or another clinical triumph of hope over experience? What should the public know? What should patients do? METHODS: Our research group has studied all three new lenses in prospective, randomized, masked, parallel clinical trials in a single center. As an outcome measure, we looked at whether lens wear caused more bacterial binding to surface corneal cells. RESULTS: Compared with conventional lens use, the new lenses caused no or only small increases in bacterial binding in either daily or extended wear. Furthermore, the increases seen stratified with known infection risks by both lens type (hard or soft) and wearing schedule. Indeed, early epidemiologic reports indicate that this new generation of lenses may reduce lens-related microbial infection risks by 10- to 40-fold. CONCLUSION: This represents a true clinical paradigm shift of the first magnitude in safety of contact lens wear. Taken together, this data suggest that patients will soon replace their current, conventional lenses with this new generation of materials for any schedule of wear.

UR - http://www.scopus.com/inward/record.url?scp=0037664660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037664660&partnerID=8YFLogxK

M3 - Article

C2 - 12772723

AN - SCOPUS:0037664660

VL - 29

JO - Eye and Contact Lense

JF - Eye and Contact Lense

SN - 1542-2321

IS - 1 Suppl

ER -